Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Classifica tra le azioni #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Prezzo delle azioni
$0.13607016
Ultima sincronizzazione: 2024-09-10
Capitalizzazione di mercato
$112.29K
Variazione (1 giorno)
22.46%
Variazione (1 anno)
0.00%
Paese
GB
Scambia BiVictriX Therapeutics Plc (BVX)

Categoria

Rapporto P/B per BiVictriX Therapeutics Plc (BVX)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di BiVictriX Therapeutics Plc, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per BiVictriX Therapeutics Plc da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE